BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
10.27
-0.10 (-0.96%)
At close: Jun 16, 2025, 3:59 PM
10.12
-1.37%
After-hours: Jun 16, 2025, 07:55 PM EDT
-0.96% (1D)
| Bid | 8.72 |
| Market Cap | 2.15B |
| Revenue (ttm) | 503.49M |
| Net Income (ttm) | -53.47M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -39.48 |
| Forward PE | 26.71 |
| Analyst | Buy |
| Ask | 10.76 |
| Volume | 2,181,694 |
| Avg. Volume (20D) | 4,493,207 |
| Open | 10.36 |
| Previous Close | 10.37 |
| Day's Range | 10.13 - 10.41 |
| 52-Week Range | 5.92 - 11.31 |
| Beta | 1.10 |
About BCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+23.52%
BioCryst Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
3 months ago
-9.99%
BioCryst Pharmaceuticals shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS estimate.
